Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pedi-Biotic
- Development stage
- Unknown
- Lead developer
- Virage Santé
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Pedi-Biotic is a **combination probiotic and prebiotic dietary supplement** formulated for infants and young children that promotes the growth and settlement of beneficial bacteria in the digestive tract[1][2][4]. Its mechanism involves colonization of the gut with specific probiotic strains and support via a prebiotic for their growth[1][2]. Each dose delivers at least 2.7 billion CFU and contains four probiotic strains: - **Lactobacillus acidophilus LAC 361** (1 billion CFU) - **Bifidobacterium longum BB536** (0.7 billion CFU) - **Bifidobacterium breve M-16** (0.5 billion CFU) - **Bifidobacterium infantis M-63** (0.5 billion CFU) The prebiotic is arabinogalactan, included to assist growth of these probiotics. The product is designed to support digestive and immune health, and may help reduce the severity and duration of diarrhea, prevent antibiotic-associated diarrhea, and promote overall gut health in children[1][2][7][3]. Pedi-Biotic is provided as a stabilized, freeze-dried powder, water-soluble, and shelf-stable at room temperature for over two years[1].
- Brand names
- Pedi-Biotic
- Other names
- Pedi-Biotic
02
Targets
Shigella spp. (Shigella species)
Beyond the preview
Go deeper on Pedi-Biotic.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pedi-Biotic.